Henry Schein, US8064071025

Henry Schein names Emmanuel Caprais CFO: what it means for Henry Schein stock

Published on 10/08/2026 at 17:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock costs EUR 74.25 on October 8, 2026 versus EUR 74.75. Second-quarter revenue reached USD 3.46 billion.

Key points in brief

  • Henry Schein appointed Emmanuel Caprais as chief financial officer effective November 4, 2026.
  • The second quarter of 2026 delivered USD 3.46 billion in revenue and USD 94.0 million in GAAP net income.
  • Henry Schein stock was at EUR 74.25 at Lang & Schwarz on October 8, 2026, versus a EUR 74.75 prior close.
  • The company is scheduled to report third-quarter results on November 3, 2026.
Moderne Zahnarztpraxis mit Behandlungsstuhl und medizinischen Instrumenten, Henry Schein Sektor
Henry Schein US42548G1040 versorgt Zahnarztpraxen weltweit mit hochwertigen medizinischen Produkten und Dentalgeräten, Illustration mit AI erstellt.

Henry Schein (ISIN US8064071025) was trading at EUR 74.25 at Lang & Schwarz on October 8, 2026 at 5:08 p.m. CEST, versus a EUR 74.75 prior close. The company named Emmanuel Caprais as senior vice president and chief financial officer effective November 4, 2026, according to StockTitan on October 8, 2026. Caprais will first join as senior financial advisor on October 12, while Ronald N. South remains CFO through November 3.

What does the CFO transition mean for costs?

The filing gives the incoming CFO an annual base salary of USD 750,000 and a target annual bonus opportunity of USD 750,000. It also sets a USD 25,000 cash sign-on bonus and an estimated USD 2.5 million grant-date value for his 2027 long-term incentive award, according to StockTitan.

For investors, the timing puts the leadership handover beside the next quarterly disclosure. South remains responsible through the third-quarter earnings process, while Caprais begins the transition before taking the CFO role.

Three dated milestones shape the story

On August 4, 2026, Henry Schein reported second-quarter revenue of USD 3.46 billion, up 6.70 percent from the second quarter of 2025, and raised its 2026 sales-growth guidance to 4.50-5.50 percent, according to the Yahoo Finance transcript. On September 22, 2026, the company amended its revolving credit agreement to increase commitments from USD 1.00 billion to USD 1.25 billion, according to MarketScreener. On October 8, 2026, Henry Schein announced Caprais's CFO appointment and South's transition to senior advisor.

Which dates matter next?

Caprais is scheduled to begin his advisory role on October 12, 2026. Henry Schein is scheduled to report third-quarter results on November 3, 2026, according to Yahoo Finance.

Stock stays below its yearly high

The Lang & Schwarz quote stood at EUR 74.25 in trading on October 8, 2026 at 5:08 p.m. CEST, down EUR 0.50 or 0.67 percent versus the EUR 74.75 prior close. On Nasdaq, the finance quote showed USD 83.27 on October 8, 2026, with a 52-week range of USD 61.95 to USD 92.18 and market capitalization of USD 9.5 billion. The further course of trading is shown by the continuously updated real-time quote of Henry Schein stock.

Henry Schein stock facts

  • Company: Henry Schein, Inc.
  • ISIN: US8064071025
  • WKN: 897961
  • Ticker: HSIC
  • Primary exchange: Nasdaq Global Select Market
  • Price Lang & Schwarz (as of October 8, 2026, 5:08 p.m. CEST): EUR 74.25
  • Change versus prior close: minus 0.67 percent
  • Prior close Lang & Schwarz (October 7, 2026): EUR 74.75
  • Market capitalization: USD 9.5 billion (as of October 8, 2026)
  • 52-week range: USD 61.95-92.18 (as of October 8, 2026)
  • Sector / Industry: Healthcare / Medical Distribution
  • Index membership: S&P 500
  • Next earnings date: November 3, 2026

Market context: Market report S&P 500.

More news and analyses on Henry Schein stock

Disclaimer...

en | US8064071025 | HENRY SCHEIN | boerse | 70268018 | bgmi